Steven J. O'Day - 18 Jun 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: Chief Medical Officer
Issuer ticker: AGEN
Reported as of: 18 Jun 2025
Net transaction value: +$194,432
SEC form: 4
Accepted by SEC: 30 Jun 2025, 16:30:24 UTC
Prior SEC filing: 18 Nov 2024
Next SEC filing: 28 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/Christine Klaskin, as attorney-in-fact for Steven O'Day

Key filing fact

Steven J. O'Day filed Form 4 for AGENUS INC (AGEN) on 30 Jun 2025.

Key facts

This page summarizes Steven J. O'Day's Form 4 filing for AGENUS INC (AGEN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Jun 2025, 16:30.

Change

Previous filing in this sequence was filed on 18 Nov 2024.
Current net transaction value: +$194,432.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001845281 Primary reporting owner

O'Day Steven J

Relationship: Chief Medical Officer
Address: C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature: /s/Christine Klaskin, as attorney-in-fact for Steven O'Day
Signature date: 30 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGEN transaction

Common Stock

Award

Transaction value: $194,432
Shares: +43,497
Change %: +319%
Price: $4.47
Shares after: 57,116
Date: 18 Jun 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects the executive's 2024 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 30-day lockup restriction with 100% of the award released on July 18, 2025.

Footnote F2

$4.47 is the closing price of our Common Stock on June 18, 2025, the stock issuance date.